Literature DB >> 12069528

Morphology of Marburg virus NP-RNA.

Manos Mavrakis1, Larissa Kolesnikova, Guy Schoehn, Stephan Becker, Rob W H Ruigrok.   

Abstract

When Marburg virus (MBGV) nucleoprotein (NP) is expressed in insect cells, it binds to cellular RNA and forms NP-RNA complexes such as insect cell-expressed nucleoproteins from other nonsegmented negative-strand RNA viruses. Recombinant MBGV NP-RNA forms loose coils that resemble rabies virus N-RNA. MBGV NP monomers are rods that are spaced along the coil similar to the nucleoprotein monomers of the rabies virus N-RNA. High salt treatment induces tight coiling of the MBGV NP-RNA, again a characteristic observed for other nonsegmented negative-strand virus N-RNAs. Electron microscopy of fixed Marburg virus particles shows that the viral nucleocapsid has a smaller diameter than the free, recombinant NP-RNA. This difference in helical parameters could be caused by the interaction of other viral proteins with the NP-RNA. A similar but opposite phenomenon is observed for rhabdovirus nucleocapsids that are condensed by the viral matrix protein upon which they acquire a larger diameter. Finally, there appears to be an extensive and regular protein scaffold between the viral nucleocapsid and the membrane that seems not to exist in the other negative-strand RNA viruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069528     DOI: 10.1006/viro.2002.1433

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread.

Authors:  Kristina Maria Schmidt; Michael Schümann; Judith Olejnik; Verena Krähling; Elke Mühlberger
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription.

Authors:  Peggy Möller; Nonia Pariente; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Functional mapping of the nucleoprotein of Ebola virus.

Authors:  Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Authors:  Reed F Johnson; Sarah E McCarthy; Peter J Godlewski; Ronald N Harty
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.

Authors:  Takeshi Noda; Shinji Watanabe; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

8.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

9.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

10.  Fungal negative-stranded RNA virus that is related to bornaviruses and nyaviruses.

Authors:  Lijiang Liu; Jiatao Xie; Jiasen Cheng; Yanping Fu; Guoqing Li; Xianhong Yi; Daohong Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.